Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial (NCT07034170) | Clinical Trial Compass
By InvitationNot Applicable
Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial
Taiwan90 participantsStarted 2025-06-01
Plain-language summary
The objective of this research project is to develop an automated muscle mass measurement system based on computed tomography (CT) images using deep learning and artificial intelligence, and to construct a prognostic prediction model for patients who have experienced cardiac arrest and undergone resuscitation. The model will be validated using multicenter registry data and medical imaging. Furthermore, a clinical trial involving core muscle rehabilitation for post-resuscitation patients will be conducted to evaluate both short-term and long-term outcomes, aiming to comprehensively understand the impact of muscle mass on the prognosis of patients after cardiac arrest.
Who can participate
Age range
18 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Non-traumatic adult patients who experienced sudden cardiac arrest
* Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation
* Admitted to the ICU
* Survived beyond 72 hours without successful weaning from mechanical ventilation
Exclusion Criteria:
* Age under 18 years
* Pregnancy
* Expected to be weaned from mechanical ventilation within 48 hours
* Terminal-stage cancer or unwillingness to receive aggressive treatment
* Unavailability of ICU care due to overcrowding in the emergency intensive care unit
* Refusal to participate in the study by the patient or family members
* Presence of an implanted pacemaker or defibrillator
* Open wounds, severe edema, or deep vein thrombosis in the lower limbs
* Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.